Voyager Therapeutics (VYGR) Revenue
Voyager Therapeutics Revenue
Voyager Therapeutics had a revenue of 3.17M in the quarter ending Jun 30, 2026, with 22.06%. This bring the company's revenue in the last twelve months to 34.46M, Decreased 5.58%. In the fiscal year ending Dec 31, 2025, Voyager Therapeutics had annual revenue of 40.37M with -49.53% growth.
- Revenue (ttm)
- 34.46M
- Revenue Growth
- -23.70%
- P/S Ratio
- 49.33
- Revenue/Employee
- MXN 286,340
- Employees
- 141
- Market Cap
- MXN 1.99B
Revenue Chart
Voyager Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.37M | -39.63M | -49.53% |
| Dec 31, 2024 | 80.00M | -170.01M | -68.00% |
| Dec 31, 2023 | 250.01M | 209.10M | 511.16% |
| Dec 31, 2022 | 40.91M | 3.49M | 9.33% |
| Dec 31, 2021 | 37.41M | -133.71M | -78.14% |
| Dec 31, 2020 | 171.13M | 66.74M | 63.93% |
| Dec 31, 2019 | 104.39M | 96.77M | 1270.14% |
| Dec 31, 2018 | 7.62M | -2.52M | -24.82% |
| Dec 31, 2017 | 10.13M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| MX:VYGR | 34.46M |